Smart Money Group’s Novo Nordisk NVO Stock Holding History

Smart Money Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,646	Closed	-$1,000K	–	88
2025 Q4	$1,000K	Buy	19,646 +1,288	+7%	+$65.9K	0.29%	51
2025 Q3	$1.02M	Buy	18,358 +4,273	+30%	+$250K	0.3%	49
2025 Q2	$972K	Buy	14,085 +2,513	+22%	+$171K	0.3%	44
2025 Q1	$804K	Buy	11,572 +5,743	+99%	+$474K	0.27%	50
2024 Q4	$501K	Sell	5,829 -1,593	-21%	-$172K	0.17%	78
2024 Q3	$831K	Buy	7,422 +555	+8%	+$74K	0.3%	53
2024 Q2	$911K	Buy	6,867 +449	+7%	+$59.5K	0.33%	45
2024 Q1	$823K	Buy	6,418 +982	+18%	+$117K	0.32%	46
2023 Q4	$562K	Buy	5,436 +566	+12%	+$56K	0.24%	47
2023 Q3	$443K	Buy	+4,870	New	+$429K	0.21%	52

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Smart Money Group's NVO Position: Q1 2026 in Review

Smart Money Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 19,646 shares — an estimated $1,000K sold.

Smart Money Group first reported a position in NVO in Q3 2023 and held it in 10 quarters. The position peaked at $1.02M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Smart Money Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Smart Money Group sold 19,646 Novo Nordisk shares in Q1 2026, an estimated $1,000K.
Smart Money Group first reported a position in Novo Nordisk in Q3 2023 and held it in 10 quarters.
Smart Money Group's Novo Nordisk position peaked at $1.02M in Q3 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Smart Money Group's 13F filing for Q1 2026, filed 5 May 2026.